Coronary vasoconstriction produced by vasopressin in anesthetized goats. Role of vasopressin V1 and V2 receptors and nitric oxide
- 26 January 1998
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 342 (2-3) , 225-233
- https://doi.org/10.1016/s0014-2999(97)01504-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Regional differences in the arterial response to vasopressin: role of endothelial nitric oxideBritish Journal of Pharmacology, 1996
- [Arg8]Vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonistsEuropean Journal of Pharmacology, 1995
- Plasma corticotrophin releasing hormone, vasopressin, ACTH and Cortisol responses to acute myocardial infarctionClinical Endocrinology, 1994
- Effects of nitric oxide synthesis inhibition on the goat coronary circulation under basal conditions and after vasodilator stimulationBritish Journal of Pharmacology, 1992
- Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.Journal of Clinical Investigation, 1991
- Effects of NG‐nitro‐l‐arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious ratsBritish Journal of Pharmacology, 1991
- Cardiovascular Actions of VasopressinPublished by Springer Nature ,1987
- Systemic and Coronary Hemodynamic Effects of VasopressinThe Lancet Healthy Longevity, 1968
- Differential actions of polypeptides and other drugs on coronary inflow vesselsAmerican Heart Journal, 1966
- SOME OBSERVATIONS ON THE CIRCULATORY EFFECTS OF OXYTOCIN, VASOPRESSIN AND SIMILAR POLYPEPTIDESPublished by Elsevier ,1965